Cerapedics’ i-FACTOR Bone Graft Featured in ISASS Bone Grafting Policy

Cerapedics announced that the International Society for the Advancement of Spine Surgery (ISASS) issued a new bone grafting policy with recommendations on use and payor coverage criterion. This statement features i-FACTOR™ Peptide Enhanced Bone Graft as one of only two drug/device combination products with Premarket Approval by FDA and support of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us